Document Classification

Section Type: RESULTS

Text: It was found by the meta-analysis that, compared with the control, at the end of the follow-up period, IFN-alpha could still significantly clear HBeAg [31. 1 % vs. 12. 4 %, odds ratio (OR) : 3. 17, 95 % CI (2. 00, 5. 02), P < 0. 000 01], clear HBV-DNA [33. 9 % vs. 16. 2 %, OR : 2. 59, 95 % CI (1. 70, 3. 96), P < 0. 0001], clear HBsAg [5. 5 % vs. 1. 2 %, OR : 3. 44, 95 % CI (1. 20, 9. 89), P = 0. 02], normalize ALT [43. 0 % vs. 27. 7 %, OR : 1. 99, 95 % CI (1. 16, 3. 42), P = 0. 01], and achieve HBeAg seroconversion [30. 4 % vs. 12. 8 %, OR : 2. 90, 95 % CI (1. 56, 5. 39), P = 0. 0008], but was not effective in HBsAg seroconversion [1. 9 % vs. 0, 95 % CI (0. 42, 18. 13), P = 0. 29].